Business ❯ Pharmaceutical Industry ❯ Regulatory Affairs

FDA

Drug Approval Process Orphan Drug Designation Sarepta Therapeutics Drug Review Process Corporate Governance Drug Applications Therapeutics Biologics License Application

FDA Rejects Regenxbio’s Hunter Syndrome Gene Therapy Application

Regenxbio plans a Type A meeting to present longer-term data with expert analyses for a swift resubmission.

Former FDA Biologics Chief Peter Marks Joins Eli Lilly to Lead Infectious Disease and Molecule Discovery

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data